Op 18 is a highly conserved major cytosolic phosphoprotein which has been implicated in signal transduction in a wide variety of cell types. Freshly isolated peripheral blood lymphocytes (PBL) constitutively express low levels of mostly unphosphorylated Op18. Following mitogenic stimulation of PBL, Op 18 synthesis is induced at a time when cells are entering S-phase. In this study we have characterized Op18 phosphorylation during progression of freshly isolated PBL through the cell cycle. Transition from GO to G1 following activation with OKT3 was associated with an increase in a phosphorylated form designated Op 18c. Progression of cells through G 1 into S resulted in an increase in phosphorylated Opl 8 forms, designated Opl8a and Op 18b, which paralleled new Op18 synthesis. Transition of cells into G2+M resulted in the appearance of the more acidic phosphorylated forms Opl8d and Opl8e. Calphostin C, a specific inhibitor of protein kinase C, dramatically decreased all forms of phosphorylated Op18 in OKT3 treated Jurkat cells. Our results suggest that Op18 phosphorylation is mediated in part by PKC activation as well as by other ldnases yielding different phosphorylated forms at specific stages of the cell cycle. ~ ~992 Academic Press, Inc.
proliferating T cells by ourselves (12) and others (3, 13, 14) following mitogenic stimulation. We have identified as many as seven phosphorylated forms of Op18 in PMA activated Jurkat cells by Western blotting (12) . Two phosphorylated forms with an apparent mass of 17.3 kD designated Opl8a and b have pI 5.80 and 5.61, respectively, compared to pI 6.0 of unphosphorylated 17.3 kD Op18. Opl8c is an 18.1 kD form with pI similar to Opl8b. Opl8d is more acidic (pI 5.42) and has greater apparent mass (18.8 kD) . Three minor 17.3 kD forms have pls 5.66, 5.48 and 5.40. We have recently described protein kinase C mediated phosphorylation of Op18 giving rise to the form designated Opl8c as early as 2 min following T cell activation (12) .
In this study we have characterized Op18 phosphorylation in freshly isolated PBL during cell cycle progression. Our results indicate a different pattern of phosphorylation related changes in Op18, at differnt stages of the cell cycle.
METHODS
Peripheral blood lymphocyte preparation and cell synchronization: Human PBL were prepared from venous blood of healthy volunteers. Whole mononuclear cells were isolated from heparanized blood by centrifugation (1500 x g, 15 rain, room temperature) over Ficoll-Paque (Pharmacia) and cultured in RPMI 1640 supplemented with 10% fetal calf serum. PBL were mitogenically stimulated with anti-CD3 (OKT3 ascites, 1:200). To achieve synchronization, 10 mM hydroxyurea was added 24 h following OKT3 stimulation and PBL were cultured for an additional 20 h to allow cells to accumulate in S phase. Cells were washed three times with media and returned to the original flask with fresh OKT3 added. Three h following release of the block in S phase, 100 ng/ml nocodazole was added for 21 h to block cells in M. The leukemia T cell line Jurkat was maintained in supplemented RPMI 1640 at a density of 0.5-1 x 106/mi.
Cell cycle analysis: The percentage of cells in G0/G1, S and G2+M was determined by DNA staining with propidium iodide (15) . Cells were fixed in 70% ethanol and incubated overnight at 4 ° C. Cells were resuspended in MEM containing 2% newborn calf serum, 500 U/ml RNase A and 0.1% sodium azide and incubated at 37 ° C for 1 h. An equal volume of 50 ~tg/ml propidium iodide in 1.12% sodium citrate, pH 8.4 was added and cells were incubated at room temperature for 30 rain. The samples were analyzed on a FACScan (Becton Dickinson). DNA content was determined by rectangular modeling using the CellFIT software program.
[32p] incorporation: Non-adherent cells (2.5 x 106 cells) were washed once with phosphatefree RPMI 1640 and resuspended in 300 ktl phosphate-free medium containing [32p]_ orthophosphate (450 ~tCi/ml, carder free; Amersham), in 1.5 ml microcentfifuge tubes. Incubation at 37 ° C was for 60 to 90 min. For inhibition studies using the specific protein kinase C (PKC) inhibitor calphostin C (Kamiya Biochemical) the working stock solution was activated by exposure to fluorescent light for 15 min prior to addition to cells (16) .
Two dimensional polyacrylamide gel electrophoresis (2-D PAGE): Two-dimensional PAGE using carrier ampholyte-based isoelectric focusing was performed as previously described (17) using pH 4-8 Resolyte (2% w/v; Hoefer Scientific). Whole cell lysates were prepared (2.5 x 106 cells) with 30 p.1 lysis solution (9.5 M urea, 2% 2-mercaptoethanol, 2% Nonidet-P40, containing 50 mM NaF and 0.1 mM Na vanadate as phosphatase inhibitors). The lysate was centrifuged for 2 rain and 2.5 x 106 cell equivalents were applied to the isofocusing gel. Focusing was for 16 h at 1000 V. The second dimension separation was an 11.4 to 15% acrylamide gradient SDS gel. Following the second dimension separation, proteins were fixed in the gel with 50% ethanol and 5% acetic acid. Gels were washed for 15 min with 2% glycerol and 30% ethanol and dried. Phosphorylated polypeptide 2-D images were obtained using a PhosphorImager System (Molecular Dynamics) (18) . Exposure time was 41 to 72 h.
RESULTS

Cell cycle analysis of PBL:
To determine whether Op18 phosphorylation is modulated during transition of ceils through the cell cycle, PBL were synchronized with a combination of hydroxyurea and nocodazole. PBL were stimulated through the T cell receptor with anti-CD3 (OKT3) for 24 h and subsequently treated with hydroxyurea, which inhibits ribonucleoside diphosphate reductase, and nocodazole, a microtubule-depolymerizing drug, to modulate transit through the cell cycle. The DNA content histogram is shown in Figure 1 . DNA content of cells was determined by FACS analysis. By 47 h, 24% of the cells entered the cell cycle (S+G2+M). (Fig. 2C ). Three h following removal of hydroxyurea, cells continued to enter S phase, however there was no significant change in Op18 phosphorylation (data not shown).
Nocodazole was then added to the medium and the incubation continued. A significant number of cells entered G2+M by 21 h of nocodazole treatment (Fig. 1) . At this time cells expressed phosphorylated Opl8d and another phosphorylated polypeptide identified as Opl8e (Fig. 2D) 
Inhibition of Op18 phosphorylation by calphostin C:
In a previous study, we observed that the early phosphorylation producing Opl8a, Opl8b and Op18c in OKT3 stimulated PBL was inhibited by calphostin C, a specific inhibitor of protein kinase C, but not by HA1004, an inhibitor of cyclic nucleotide-dependent protein kinases (12) . To determine the involvement of protein kinase C in Opl8d and Opl8e phosphorylation we examined phosphorylation patterns in Jurkat cells. Jurkat cells treated with OKT3 express all five of these phosphorylated forms of Op 18 (Fig.  3A) . When Jurkat cells were treated with calphostin C (1.26 ~tM) during the prelabeling period and were subsequently treated with OKT3 for 15 rain there was a dramatic decrease in the extent of 
